Medical Cannabis Safety, Side Effects & Drug Interactions

Persistent pain — defined in Utah as pain lasting more than two weeks that has not responded adequately to conventional treatment — is the most common qualifying condition for medical cannabis in Utah and nationally. Research suggests that cannabinoids may interact with the body's endocannabinoid system to modulate pain signaling, reduce inflammation, and improve pain tolerance. Some patients with chronic musculoskeletal pain, nerve pain, and fibromyalgia report meaningful relief with cannabis-based therapies, particularly when conventional medications have been ineffective or caused significant side effects.

Post-traumatic stress disorder (PTSD) is one of the most researched areas of medical cannabis use. Studies suggest that cannabinoids may help regulate the fear response, reduce hyperarousal, and improve sleep quality in patients with PTSD — areas where conventional treatments often fall short. The endocannabinoid system plays a role in fear memory extinction, and early research indicates cannabis may support this process. Medical cannabis is not a cure for PTSD but may be a meaningful part of a comprehensive treatment plan under physician supervision.

Cancer patients may qualify when experiencing pain, nausea, cachexia, or other debilitating symptoms related to their disease or treatment. Research suggests cannabis may help manage chemotherapy-induced nausea, stimulate appetite, and provide pain relief. Dr. Law will evaluate your specific situation and symptoms at your appointment.

Epilepsy and debilitating seizure disorders are among the most well-established qualifying conditions for medical cannabis. CBD — a non-intoxicating cannabinoid — has demonstrated significant anticonvulsant properties in clinical trials, leading to FDA approval of a CBD-based medication (Epidiolex) for certain severe epilepsy syndromes. For patients whose seizures have not responded to conventional anti-epileptic medications, medical cannabis may offer a meaningful therapeutic option under careful physician supervision.

Multiple sclerosis (MS) frequently causes debilitating muscle spasticity, pain, and bladder dysfunction. Research suggests that cannabinoids may help reduce muscle spasm frequency and severity, improve sleep, and provide pain relief in MS patients. Several countries have approved cannabis-based medications specifically for MS-related spasticity, and clinical guidelines in some jurisdictions now include cannabis as an option for patients who have not responded adequately to conventional spasticity treatments.

HIV/AIDS and its treatments can cause chronic pain, nausea, nerve damage, and significant weight loss. Medical cannabis may help manage these symptoms, supporting quality of life and appetite in patients living with HIV/AIDS. Dr. Law can evaluate whether medical cannabis is appropriate as part of your overall care plan.

Crohn's disease causes chronic inflammation of the digestive tract, leading to severe abdominal pain, diarrhea, and significant quality of life impairment. Research suggests cannabinoids may help reduce gut inflammation, decrease pain, and improve appetite in Crohn's patients. Some patients report meaningful symptom relief when conventional treatments have been only partially effective.

Ulcerative colitis is a chronic inflammatory bowel disease causing abdominal pain, urgent diarrhea, and significant disruption to daily life. Research suggests cannabinoids may help reduce intestinal inflammation and improve symptom control in some patients. Medical cannabis may be considered as part of a comprehensive treatment approach when conventional therapies have been insufficient.

Persistent nausea that has not responded adequately to conventional antiemetic medications can be significantly debilitating and is a recognized qualifying condition in Utah. Cannabinoids have strong scientific support as antiemetic agents — THC in particular has been shown to reduce nausea and vomiting through its interaction with the endocannabinoid system. Medical cannabis may offer relief for patients whose nausea has not responded to standard treatments.

Alzheimer's disease can cause significant behavioral symptoms including agitation, aggression, sleep disturbances, and anxiety that are difficult to manage with conventional medications. Research suggests cannabinoids may help reduce agitation and improve sleep quality in Alzheimer's patients. Medical cannabis may offer a gentler alternative or complement to conventional behavioral medications under physician supervision.

ALS is a progressive neurodegenerative disease causing muscle weakness, spasticity, pain, and difficulty swallowing and breathing. Research suggests cannabinoids may help manage several ALS symptoms including muscle spasms, pain, excessive saliva production, and sleep disturbances. Medical cannabis may offer meaningful quality of life improvements for ALS patients when supervised by a physician.

Autism spectrum disorder (ASD) can involve significant behavioral challenges, anxiety, self-injurious behavior, and sleep disturbances that are difficult to manage with conventional approaches. Emerging research suggests cannabinoids — particularly CBD — may help reduce certain behavioral symptoms and improve quality of life in some ASD patients. Medical cannabis for autism requires careful physician evaluation and supervision given the complexity of the condition.

Cachexia is a complex metabolic condition involving severe involuntary weight loss, muscle wasting, and fatigue — most commonly associated with cancer, HIV/AIDS, and other serious illnesses. Research strongly supports cannabis as an appetite stimulant and weight stabilizer in cachexia patients. THC in particular has well-documented appetite-stimulating properties that may help patients maintain weight during serious illness.

Patients receiving hospice care or facing a terminal illness with a prognosis of six months or less automatically qualify for medical cannabis in Utah. Cannabis may help manage pain, anxiety, nausea, and sleep disturbances at end of life, supporting comfort and dignity. Dr. Law approaches these evaluations with particular sensitivity and can coordinate with your existing care team.

Utah law also allows medical cannabis for rare conditions — defined as those affecting fewer than 200,000 Americans according to the NIH definition. If you have a rare diagnosis not specifically listed among Utah's qualifying conditions, you may still qualify. Dr. Law will review your medical records and history at your evaluation to determine eligibility.